“We were able to utilize Atropos Health to evaluate medications for formulary consideration. Real World Evidence (RWE ) enabled us to understand patient outcomes on these therapies and resulted in removal or restriction of the medications from the formulary. These findings were presented at the Institute for Healthcare Improvement (IHI) conference.”